Your browser doesn't support javascript.
loading
miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells.
Rasmussen, Mads Heilskov; Lyskjær, Iben; Jersie-Christensen, Rosa Rakownikow; Tarpgaard, Line Schmidt; Primdal-Bengtson, Bjarke; Nielsen, Morten Muhlig; Pedersen, Jakob Skou; Hansen, Tine Plato; Hansen, Flemming; Olsen, Jesper Velgaard; Pfeiffer, Per; Ørntoft, Torben Falck; Andersen, Claus Lindbjerg.
Afiliação
  • Rasmussen MH; Department of Molecular Medicine, Department of Clinical Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200 Aarhus, Denmark.
  • Lyskjær I; Department of Molecular Medicine, Department of Clinical Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200 Aarhus, Denmark.
  • Jersie-Christensen RR; Department of Proteomics, Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Blegdamsvej 3b, DK-2200 Copenhagen, Denmark.
  • Tarpgaard LS; Institute of Clinical Research, University of Southern Denmark, Winsløwparken 19, DK-5000 Odense, Denmark.
  • Primdal-Bengtson B; Department of Molecular Medicine, Department of Clinical Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200 Aarhus, Denmark.
  • Nielsen MM; Department of Molecular Medicine, Department of Clinical Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200 Aarhus, Denmark.
  • Pedersen JS; Department of Molecular Medicine, Department of Clinical Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200 Aarhus, Denmark.
  • Hansen TP; Department of Pathology, Institute of Clinical Research, Odense University Hospital, Winsløwparken 15, DK-5000 Odense, Denmark.
  • Hansen F; Department of Oncology, Aarhus University Hospital, Nørrebrogade 44, DK-8200 Aarhus, Denmark.
  • Olsen JV; Department of Proteomics, Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Blegdamsvej 3b, DK-2200 Copenhagen, Denmark.
  • Pfeiffer P; Institute of Clinical Research, University of Southern Denmark, Winsløwparken 19, DK-5000 Odense, Denmark.
  • Ørntoft TF; Department of Oncology, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense, Denmark.
  • Andersen CL; Department of Molecular Medicine, Department of Clinical Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200 Aarhus, Denmark.
Nat Commun ; 7: 12436, 2016 08 16.
Article em En | MEDLINE | ID: mdl-27526785
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Regulação Neoplásica da Expressão Gênica / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / MAP Quinase Quinase 6 / Proteínas Quinases p38 Ativadas por Mitógeno Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Regulação Neoplásica da Expressão Gênica / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / MAP Quinase Quinase 6 / Proteínas Quinases p38 Ativadas por Mitógeno Idioma: En Ano de publicação: 2016 Tipo de documento: Article